Home Logon FTA Investment Managers Blog Subscribe About Us Contact Us

Search by Ticker, Keyword or CUSIP       
Blog Home
Bob Carey
Chief Market Strategist
X •  LinkedIn

  The Push to Bring New Drugs to Market Faster is On
Posted Under: Sectors
Supporting Image for Blog Post


View from the Observation Deck

  1. The Prescription Drug User Fee Act (PDUFA) is up for renewal by Congress in 2012. It was last renewed in 2007.
  2. PDUFA authorizes the U.S. Food and Drug Administration (FDA) to collect user fees from certain drug manufacturers.
  3. Both the House of Representatives and the Senate just passed their respective versions overwhelmingly.
  4. The next step is to settle any differences between the bills. A combined PDUFA bill is expected to be passed into law this summer.
  5. New language in the revisions includes an accelerated approval process to "fast track" new drugs aimed at rare diseases. (Quest)
  6. There were 30 new drug approvals in 2011 – a 7-year high, but the number is right at the average for the past 16 years.
  7. While the safety-conscious FDA has made the drug approval process more difficult through the years, drug companies are getting better at choosing which treatments to bring to market. (FierceBiotech)
  8. We believe, if passed, that this provision could be a positive development for the drug industry, and one that investors should keep abreast of.
Posted on Tuesday, June 19, 2012 @ 2:56 PM • Post Link Print this post Printer Friendly

These posts were prepared by First Trust Advisors L.P., and reflect the current opinion of the authors. They are based upon sources and data believed to be accurate and reliable. Opinions and forward looking statements expressed are subject to change without notice. This information does not constitute a solicitation or an offer to buy or sell any security.
Search Posts
Market Commentary and Analysis
Market Commentary Video
Monthly Talking Points
Quarterly Newsletter
Market Observations
Subscribe To Receive Email

Earnings and Opportunities
The Buy and Hold Investment Strategy Is Not Dead!
Treasury Returns May Be About To Hit A Wall On Two Fronts
Why Cash is Still King
Takes More And More Stimulus To Move An Economy This Big
Retail Investors Give Stocks A No Confidence Vote
Time to Develop an Exit Plan from Intermediate & L-T Treasuries
Don't Fear Stocks If Inflation Climbs Above 3.0%
Investors Have to Make a Decision
The Business of Energy Distribution
Skip Navigation Links.
Search by Topic
Skip Navigation Links.

The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
Follow First Trust:  
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2023 All rights reserved.